share_log

Walgreens Launches Inaugural Patient Advisory Board to Advance Access and Representation in Clinical Research

Walgreens Launches Inaugural Patient Advisory Board to Advance Access and Representation in Clinical Research

沃爾格林公司啓動首個患者諮詢委員會,以推動臨床研究中的可及性和代表性
沃爾格林-聯合博姿 ·  12/13 13:00

DEERFIELD, Ill.--DEC. 13, 2024-- With a history of more than 120 years serving communities across the country, Walgreens prides itself in being a trusted retail pharmacy partner for more than 9 million patients and customers it serves each day. Walgreens is amplifying its commitment to its patients and partners through the formation of the Walgreens Clinical Trials Patient Advisory Board. Since its launch in June 2022, the Walgreens Clinical Trials team has reached more than 7 million patients to potentially recruit into sponsor-led clinical trials. As the team continues expanding its scope and raising awareness about the importance of community-centered clinical research, the Patient Advisory Board members will offer key patient insights that are an invaluable resource to the delivery and advancement of clinical trials.

伊利諾伊州迪爾菲爾德--2024年12月13日——沃爾格林擁有超過120年的爲全國各地社區提供服務的歷史,以成爲每天爲900萬多名患者和客戶提供服務的值得信賴的零售藥房合作伙伴而感到自豪。通過成立沃爾格林臨床試驗患者諮詢委員會,沃爾格林正在擴大其對患者和合作夥伴的承諾。自2022年6月啓動以來,沃爾格林臨床試驗團隊已經接觸了超過700萬名患者,有可能招募他們參加由贊助者主導的臨床試驗。隨着該團隊繼續擴大其範圍並提高人們對以社區爲中心的臨床研究重要性的認識,患者顧問委員會成員將提供關鍵的患者見解,這些見解是開展和推進臨床試驗的寶貴資源。

The inaugural Patient Advisory Board consists of 10 patient experts who will leverage both lived and learned experiences to inform clinical trial recruitment and retention efforts to increase access and representation in clinical research in communities that have historically been excluded. Ramita Tandon, chief biopharma services officer, is standing up the Board as part of Walgreens' commitment to bringing community-based clinical research to more people that may benefit from it.

首屆患者顧問委員會由10位患者專家組成,他們將利用生活和學到的經驗,爲臨床試驗的招募和保留工作提供信息,以增加歷來被排除在外的社區中臨床研究的機會和代表性。首席生物製藥服務官拉米塔·坦登正在組建董事會,這是沃爾格林承諾將基於社區的臨床研究帶給更多可能從中受益的人群的承諾的一部分。

"I am proud to engage with our inaugural cohort of Patient Advisory Board members to increase awareness and representation in clinical trials. Only 5% of the U.S. population participates in clinical trials and nearly 80% of trials fail to meet their enrollment goals, often contributing to delays in bringing new medications to patients," said Tandon. "Our Patient Advisory Board members will help inform how we approach our sponsor-led clinical trials to better serve our patients and partners."

「我很自豪能與我們的首批患者顧問委員會成員互動,以提高臨床試驗的認識和代表性。坦登說,只有5%的美國人口參與臨床試驗,將近80%的試驗未能實現入組目標,這通常會導致延遲向患者提供新藥。」「我們的患者顧問委員會成員將幫助告知我們如何開展由贊助商主導的臨床試驗,以更好地爲我們的患者和合作夥伴服務。」

With increasing regulatory focus on incorporating patients' perspectives in medical product development,1,2 and the growth of precision medicine,3 now more than ever, it's important to engage with patients and individuals who have had experience with clinical research as their lived experiences offer an opportunity to continue improving clinical trials to best serve patients.

隨着監管機構越來越注重將患者的觀點納入醫療產品開發,1,2以及精準醫療3的發展,現在比以往任何時候都更加重要,與有臨床研究經驗的患者和個人進行接觸非常重要,因爲他們的生活經歷爲繼續改善臨床試驗提供了機會,從而爲患者提供最佳服務。

Walgreens Clinical Trials Patient Advisory Board members will commit to serve a 2-year term and will offer ongoing counsel, diverse thinking and expertise to inform Walgreens Clinical Trials efforts.

沃爾格林臨床試驗患者顧問委員會成員將承諾任期兩年,並將提供持續的諮詢、多元化的思維和專業知識,爲沃爾格林臨床試驗工作提供信息。

Learn more about Walgreens Clinical Trials here.

在此處了解有關沃爾格林臨床試驗的更多信息。

About Walgreens

關於沃爾格林

Founded in 1901, Walgreens () has a storied heritage of caring for communities for generations, and proudly serves nearly 9 million customers and patients each day across its approximately 8,500 stores throughout the U.S. and Puerto Rico, and leading omni-channel platforms. Walgreens has approximately 220,000 team members, including nearly 90,000 healthcare service providers, and is committed to being the first choice for retail pharmacy and health services, building trusted relationships that create healthier futures for customers, patients, team members and communities.

Walgreens () 成立於1901年,擁有幾代人關愛社區的傳奇傳統,並自豪地通過其遍佈美國和波多黎各的約8,500家門店以及領先的全渠道平台每天爲近900萬名客戶和患者提供服務。Walgreens擁有約22萬名團隊成員,其中包括近90,000名醫療保健服務提供商,並致力於成爲零售藥房和醫療服務的首選,建立信任關係,爲客戶、患者、團隊成員和社區創造更健康的未來。

Walgreens is the flagship U.S. brand of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), an integrated healthcare, pharmacy and retail leader. Its retail locations are a critical point of access and convenience in thousands of communities, with Walgreens pharmacists playing a greater role as part of the healthcare system and patients' care teams than ever before. Walgreens Specialty Pharmacy provides critical care and pharmacy services to millions of patients with rare disease states and complex, chronic conditions.

沃爾格林是綜合醫療保健、製藥和零售領導者沃爾格林靴子聯盟公司(納斯達克股票代碼:WBA)的美國旗艦品牌。其零售地點是成千上萬個社區的關鍵准入點和便利點,沃爾格林的藥劑師作爲醫療保健系統和患者護理團隊的一部分所發揮的作用比以往任何時候都更加重要。沃爾格林專業藥房爲數百萬患有罕見病狀態和複雜慢性病的患者提供重症監護和藥房服務。

  1. Patient Engagement Collaborative.
  2. Patient-Focused Drug Development: Workshop to Discuss Methodologic and Other Challenges Related to Patient Experience Data. December 13, 2024
  1. 患者參與協作。
  2. 以患者爲中心的藥物開發:討論與患者體驗數據相關的方法學和其他挑戰的研討會。2024 年 12 月 13 日

Media Contact

媒體聯繫人

Carmen Lopez
media@walgreens.com

卡門洛佩茲
media@walgreens.com

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論